Facebook
X
LinkedIn
ForwardCOURSE DIRECTOR
David McClintock, M.D.
Katelyn Reed, M.H.S.
DESCRIPTION
This series offers a comprehensive exploration of artificial intelligence’s transformative potential in laboratory medicine, covering fundamental technologies, practical applications, and ethical considerations. The series will provide insights into cutting-edge AI technologies, their current implementation in pathology, and future opportunities for innovation and improvement in clinical processes.
In-Person and Live-Streamed; Every other Month on a Monday from 12:00-1:00 p.m.
TARGET AUDIENCE
Allied Health Professionals, Healthcare Executives, Physicians, Scientist Researcher PhDs and Students.
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
- Describe ethical and regulatory considerations that must be addressed before implementing AI tools in clinical practice.
- Identify at least two ways AI adoption in the laboratory can impact patient care, such as reducing unnecessary testing or enhancing predictive diagnostics.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CREDIT STATEMENT(S)
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACHE
By attending the MCSCPD Education Development Grand Round offered by Mayo Clinic College of Medicine and Science participants may earn up to 1.00 ACHE Qualifying Education Hours toward initial certification or recertification of the Fellow of the American College of Healthcare Executives (FACHE) designation.
DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. All who are in a position to control the content are required to disclose all financial relationships with any ineligible company. Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
Listed below are individuals with control of the content of this program who have disclosed...
Relevant financial relationship(s) with ineligible companies:
David McClintock, M.D. - Honoraria - Abbott Laboratories, Philips Electronics, Roche Diagnostics Corporation, and Roche Molecular Systems, Inc.
All relevant financial relationships have been mitigated.
No relevant financial relationship(s) with ineligible companies:
Debra Novak, M.B.A.
Katelyn Reed, M.H.S.
References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.
TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.
QUESTIONS?
Contact Emma Walsh